Fewer Than Half of Stroke Patients Receive Indicated Dual-Antiplatelet Therapy

Dr. Mitchell S.V. Elkind, who also was not part of the study, agreed that it can take a long time for guidelines to make their way into clinical practice. "We need to do a better job educating practicing neurologists and others who care for stroke patients about the benefits of DAPT," said Dr. Elkind, a professor of neurology and epidemiology at Columbia University Vagelos College of Physicians and Surgeons, in New York City, and recent past president of the American Heart Association. [read more]

Source: Reuters